HEALEY ALS Platform Trial - Regimen F ABBV-CLS-7262

Clinical trial NCT05740813 · COMPLETED

Trial details

NCT number: NCT05740813
Sponsor: Merit E. Cudkowicz, MD
Status: COMPLETED
Phase: Phase 2, Phase 3
Study type: INTERVENTIONAL

Amyotrophic Lateral Sclerosis

Start date: 2023-03-23
Primary completion: 2024-10-03
Enrollment: 310

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.